Ignis Therapeutics
Shanghai, China · Founded 2020 · $180.0M raised
- Headquarters
- Shanghai
- Founded
- 2020
- Business Model
- B2B
- Website
- ignistherapeutics.com
- Total Funding
- $180.0M
- Last Round
- $180.0M Series AJun 2021
- Rounds
- 1
About
Biopharmaceutical company
Summary
Ignis Therapeutics is a Biotech company based in Shanghai, China, founded in 2020. It has raised $180.0M in total across 1 round, most recently a $180.0M Series A round in Jun 2021. Investors include 6 Dimensions Capital, Ruentex Group and KB Investment.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jun 2021
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.